These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12036353)

  • 1. Design of selective thrombin inhibitors based on the (R)-Phe-Pro-Arg sequence.
    Danilewicz JC; Abel SM; Brown AD; Fish PV; Hawkeswood E; Holland SJ; James K; McElroy AB; Overington J; Powling MJ; Rance DJ
    J Med Chem; 2002 Jun; 45(12):2432-53. PubMed ID: 12036353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly selective tripeptide thrombin inhibitors.
    Shuman RT; Rothenberger RB; Campbell CS; Smith GF; Gifford-Moore DS; Gesellchen PD
    J Med Chem; 1993 Feb; 36(3):314-9. PubMed ID: 8426361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of potential thrombin inhibitors. Incorporation of tartaric acid templates as P2 proline mimetics.
    Dahlgren A; Brånalt J; Kvarnström I; Nilsson I; Musil D; Samuelsson B
    Bioorg Med Chem; 2002 May; 10(5):1567-80. PubMed ID: 11886818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3, 5-difluoro-6-[3-(4, 5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylgl y cine (ZK-807834): a potent, selective, and orally active inhibitor of the blood coagulation enzyme factor Xa.
    Phillips GB; Buckman BO; Davey DD; Eagen KA; Guilford WJ; Hinchman J; Ho E; Koovakkat S; Liang A; Light DR; Mohan R; Ng HP; Post JM; Shaw KJ; Smith D; Subramanyam B; Sullivan ME; Trinh L; Vergona R; Walters J; White K; Whitlow M; Wu S; Xu W; Morrissey MM
    J Med Chem; 1998 Sep; 41(19):3557-62. PubMed ID: 9733480
    [No Abstract]   [Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of selective boron-containing thrombin inhibitors.
    Wienand A; Ehrhardt C; Metternich R; Tapparelli C
    Bioorg Med Chem; 1999 Jul; 7(7):1295-307. PubMed ID: 10465405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. 5. Potency, efficacy, and pharmacokinetic properties of modified C-3 side chain derivatives.
    Sall DJ; Bailey DL; Bastian JA; Buben JA; Chirgadze NY; Clemens-Smith AC; Denney ML; Fisher MJ; Giera DD; Gifford-Moore DS; Harper RW; Johnson LM; Klimkowski VJ; Kohn TJ; Lin HS; McCowan JR; Palkowitz AD; Richett ME; Smith GF; Snyder DW; Takeuchi K; Toth JE; Zhang M
    J Med Chem; 2000 Feb; 43(4):649-63. PubMed ID: 10691691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin.
    Ganesh V; Lee AY; Clardy J; Tulinsky A
    Protein Sci; 1996 May; 5(5):825-35. PubMed ID: 8732754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary structure peptide mimetics: design, synthesis, and evaluation of beta-strand mimetic thrombin inhibitors.
    Boatman PD; Ogbu CO; Eguchi M; Kim HO; Nakanishi H; Cao B; Shea JP; Kahn M
    J Med Chem; 1999 Apr; 42(8):1367-75. PubMed ID: 10212122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
    Bhunia SS; Roy KK; Saxena AK
    J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of L-proline based aeruginosin 298-A analogs: optimization of the P1-moiety.
    Wang G; Goyal N; Hopkinson B
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3798-803. PubMed ID: 19447619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide-derived transition state analogue inhibitors of thrombin; synthesis, activity and selectivity.
    Jetten M; Peters CA; Visser A; Grootenhuis PD; van Nispen JW; Ottenheijm HC
    Bioorg Med Chem; 1995 Aug; 3(8):1099-114. PubMed ID: 7582983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative molecular modeling analysis of-5-amidinoindole and benzamidine binding to thrombin and trypsin: specific H-bond formation contributes to high 5-amidinoindole potency and selectivity for thrombin and factor Xa.
    Zhou Y; Johnson ME
    J Mol Recognit; 1999; 12(4):235-41. PubMed ID: 10440994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncovalent thrombin inhibitors incorporating an imidazolylethynyl P1.
    Lee K; Jung WH; Kang M; Lee SH
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2775-8. PubMed ID: 11133089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptides and pseudopeptides incorporating D-Phe-Pro-Arg and Arg-Gly-Asp lead sequences as potential antithrombotic agents.
    Ilas J; Hudecz F; Süli-Vargha H; Kikelj D
    J Pept Sci; 2008 Aug; 14(8):946-53. PubMed ID: 18383437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease inhibitors: synthesis and QSAR study of novel classes of nonbasic thrombin inhibitors incorporating sulfonylguanidine and O-methylsulfonylisourea moieties at P1.
    Supuran CT; Scozzafava A; Briganti F; Clare BW
    J Med Chem; 2000 May; 43(9):1793-806. PubMed ID: 10794696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxyguanidines. Part 2: Discovery of a novel orally active thrombin inhibitor through structure-based drug design and parallel synthesis.
    Lu T; Markotan T; Coppo F; Tomczuk B; Crysler C; Eisennagel S; Spurlino J; Gremminger L; Soll RM; Giardino EC; Bone R
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3727-31. PubMed ID: 15203151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacious and orally bioavailable thrombin inhibitors based on a 2,5-thienylamidine at the P1 position: discovery of N-carboxymethyl-d-diphenylalanyl-l-prolyl[(5-amidino-2-thienyl)methyl]amide.
    Lee K; Park CW; Jung WH; Park HD; Lee SH; Chung KH; Park SK; Kwon OH; Kang M; Park DH; Lee SK; Kim EE; Yoon SK; Kim A
    J Med Chem; 2003 Aug; 46(17):3612-22. PubMed ID: 12904065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterisation of novel thrombin inhibitors based on 4-amidinophenylalanine.
    Reers M; Koschinsky R; Dickneite G; Hoffmann D; Czech J; Stüber W
    J Enzyme Inhib; 1995; 9(1):61-72. PubMed ID: 8568567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncovalent tripeptidic thrombin inhibitors incorporating amidrazone, amine and amidine functions at P1.
    Lee K; Jung WH; Park CW; Park HD; Lee SH; Kwon OH
    Bioorg Med Chem Lett; 2002 Apr; 12(7):1017-22. PubMed ID: 11909707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.